These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8179963)

  • 1. Retrovirus vector-mediated transfer of functional HIV-1 regulatory genes.
    Garcia JV; Miller AD
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):47-52. PubMed ID: 8179963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrovirus-mediated transfer and long-term expression of HIV type 1 tat gene in murine hematopoietic tissues.
    Frazier AL; Garcia JV
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1517-9. PubMed ID: 7888206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
    Srinivasakumar N; Chazal N; Helga-Maria C; Prasad S; Hammarskjöld ML; Rekosh D
    J Virol; 1997 Aug; 71(8):5841-8. PubMed ID: 9223473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
    Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
    Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1.
    Davis AJ; Li P; Burrell CJ
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1897-906. PubMed ID: 9266985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
    Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
    Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
    Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
    Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.
    Federico M; Nappi F; Ferrari G; Chelucci C; Mavilio F; Verani P
    J Virol; 1995 Nov; 69(11):6618-26. PubMed ID: 7474070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
    Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
    J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector.
    Tähtinen M; Strengell M; Collings A; Pitkänen J; Kjerrström A; Hakkarainen K; Peterson P; Kohleisen B; Wahren B; Ranki A; Ustav M; Krohn K
    Vaccine; 2001 Feb; 19(15-16):2039-47. PubMed ID: 11228375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
    Liem SE; Ramezani A; Li X; Joshi S
    Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rev-induced modulation of Nef protein underlies temporal regulation of human immunodeficiency virus replication.
    Ahmad N; Maitra RK; Venkatesan S
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6111-5. PubMed ID: 2788283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of a biologically contained replication system for human immunodeficiency virus type 1.
    Chen H; Boyle TJ; Malim MH; Cullen BR; Lyerly HK
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7678-82. PubMed ID: 1502183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV type 1 replication in chronically infected monocytes and lymphocytes by retrovirus-mediated gene transfer of anti-Rev single-chain variable fragments.
    Ho WZ; Lai JP; Bouhamdan M; Duan L; Pomerantz RJ; Starr SE
    AIDS Res Hum Retroviruses; 1998 Nov; 14(17):1573-80. PubMed ID: 9840290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A third-generation lentivirus vector with a conditional packaging system.
    Dull T; Zufferey R; Kelly M; Mandel RJ; Nguyen M; Trono D; Naldini L
    J Virol; 1998 Nov; 72(11):8463-71. PubMed ID: 9765382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes.
    Bahner I; Zhou C; Yu XJ; Hao QL; Guatelli JC; Kohn DB
    J Virol; 1993 Jun; 67(6):3199-207. PubMed ID: 8388497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.
    Scriba TJ; zur Megede J; Glashoff RH; Treurnicht FK; Barnett SW; van Rensburg EJ
    Vaccine; 2005 Jan; 23(9):1158-69. PubMed ID: 15629359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.
    Kjerrström A; Hinkula J; Engström G; Ovod V; Krohn K; Benthin R; Wahren B
    Virology; 2001 May; 284(1):46-61. PubMed ID: 11352667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.